You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

58 Items

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Document Status: Current
ID: GL 17-12
Version: N/A

Sep 2019

Kadcyla® Trastuzumab Emtansine Safety Reminder

Document Status: Current
ID: GL-C50-15

Jun 2014

Locoregional Management of In-Transit Metastasis in Melanoma

Document Status: Current
ID: GL 8-10
Version: N/A

Feb 2020

Management of Cancer Medication-Related Infusion Reactions

Document Status: Current
Version: 1

Aug 2019

Management of Early-Stage Hodgkin Lymphoma

Document Status: Current
ID: GL 6-20
Version: 2

May 2023

Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Document Status: Current
ID: GL SCT-8

Oct 2017

Management of Squamous Cell Cancer of the Anal Canal

Document Status: Current
ID: 2-8
Version: 2

Feb 2014

Oncology Caregiver Support Framework

Document Status: Current
ID: N/A
Version: N/A

Oct 2019

Optimal Treatment Strategies for Localized Ewing's Sarcoma of Bone after Neoadjuvant Chemotherapy

Document Status: Current
ID: 11-6
Version: 2

Feb 2022

Organizational Guidance for the Care of Patients with Central Nervous System Tumours in Ontario: Consensus Recommendations

Document Status: Current
ID: GL 9-11

Oct 2024

Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario

Document Status: Current
ID: GL 5-3ORG
Version: 2

Apr 2019

Organizational Requirements for Acute Leukemia Service Providers in Ontario: Recommendations Report 2024

Document Status: Current
Version: 2

Dec 2024